Specifications include, but are not limited to: The purposes of issuing this RFI are to: A. Identify potential cost savings to the State of Connecticut (State) by consolidating drug purchasing, if any; B. Determine the administrative feasibility to the State of consolidating drug purchasing; C. Understand the overlap, if any, between prescription and physician-administered drugs purchased by state agencies, state hospitals, state-operated local mental health authorities and any other public entities and identify areas for improvement with pricing; D. Determine, benefits and risks of centralizing and consolidating such contracts; and E. Determine whether any additional staff and resources would be required by the Comptroller to centrally procure and administer such contracts.
